Vector-borne diseases continue to pose significant global health challenges due to their widespread transmission by vectors such as mosquitoes, ticks, ...
There was no association observed between respiratory syncytial virus vaccination and increased risk for atrial fibrillation in older adults with preexisting conditions, supporting the use of RSV ...
Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively ...
Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more likely among people with other health issues and who ...
Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...